May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Excess Biglycan Blocks TGF Signaling for Eyelid Morphogenesis during Development of Kera-Bgn Transgenic Mice
Author Affiliations & Notes
  • W.Y. Kao
    Ophthalmology, University of Cincinnati, Cincinnati, OH, United States
  • Y. Hayashi
    Ophthalmology, University of Cincinnati, Cincinnati, OH, United States
  • C. Liu
    Ophthalmology, University of Cincinnati, Cincinnati, OH, United States
  • C.W. Kao
    Ophthalmology, University of Cincinnati, Cincinnati, OH, United States
  • M. Hayashi
    Ophthalmology, University of Cincinnati, Cincinnati, OH, United States
  • J.L. Funderburgh
    Ophthalmology, University of Pittsburgh, Pittsburgh, PA, United States
  • P.J. Roughley
    Genetic Unit, Shriners Hospital, Montreal, PQ, Canada
  • I. Wang
    Ophthalmology, National Taiwan University, Taipei, Taiwan Republic of China
  • S. Saika
    Ophthalmology, University of Wakayama, Wakayama, Japan
  • J.V. Jester
    Ophthalmology, University of Texas, Dallas, TX, United States
  • Footnotes
    Commercial Relationships  W.Y. Kao, None; Y. Hayashi, None; C. Liu, None; C.W.C. Kao, None; M. Hayashi, None; J.L. Funderburgh, None; P.J. Roughley, None; I. Wang, None; S. Saika, None; J.V. Jester, None.
  • Footnotes
    Support  NIH Grants EY 11845, EY13755
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2143. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W.Y. Kao, Y. Hayashi, C. Liu, C.W. Kao, M. Hayashi, J.L. Funderburgh, P.J. Roughley, I. Wang, S. Saika, J.V. Jester; Excess Biglycan Blocks TGF Signaling for Eyelid Morphogenesis during Development of Kera-Bgn Transgenic Mice . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2143.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Tissue morphogenesis during development involves constant remodeling of extracellular matrix and signal transduction. In present studies, we examined the effects of excess biglycan on eyelid morphogenesis during mouse development. Methods: Transgenic mice over expressing biglycan by keratocan promoter (Bgn-tg) were subjected to morphological examinations using HE staining, TUNEL assay, and BrdU incorporation, and immunohistochemistry by light, confocal and scan electron microscopy; and molecular and biochemical analysis for the expression of biglycan, α-smooth muscle actin. Biglycan and neutralizing antibodies against TGFα, TGFß, activin ßB and EGFR were included in the medium of an in vitro assay of mesenchymal cell migration induced by eyelid epithelium. Results: Adult Bgn-tg mice exhibit eyelid malformation characteristics of exposure keratitis: 1. thin eyelid stroma with fewer eyelid stromal cells, 2. premature eye opening due to non-infectious eyelid ulceration, 3. absence of Meibomian glands, 4. no enhanced apoptosis nor decreased cell proliferation. In Bgn-tg mice actin stress fiber was under developed in mesenchymal cells and malformation of orbicularis oculi muscle as revealed by confocal microscopy using anti-α smooth muscle actin antibody in comparison to those of wild type littermates. In vitro analysis revealed that biglycan, and anti-TGFα and -EGFR antibodies effectively inhibit mesenchymal cells migration induced by eyelid epithelium. Western blot analysis with anti-biglycan antibodies of immune precipitates of neutralizing antibodies indicates biglycan binds to TGFα. Conclusions Our observations suggest that during embryonic development excess biglycan sequesters TGFα and impairs eyelid morphogenesis via perturbation of the migration of periocular mesenchymal cells of neural crest origin and the differentiation of orbicularis oculi muscle.

Keywords: transgenics/knock-outs • eyelid • extracellular matrix 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×